Skip to main content
. 2021 Feb 10;218(4):e20201803. doi: 10.1084/jem.20201803

Figure S5.

Figure S5.

Pathways changed in cluster 1 in patient PMNs. AHR, aryl hydrocarbon receptor (AHR); AMPK, AMP-activated protein kinase; EGF, epidermal growth factor; eNOS, endothelial NOS; FGF, fibrobalst growth factor; HGF, hepatocyte growth factor; mTOR, mechanistic target of rapamcyin; NGF, nerve growth factor; PDGF, platelet derived growth factor; PPAR, peroxisome proliferator-activated receptors; VEGF, vascular endothelial growth factor.